320 likes | 508 Views
ANTISEIZURE DRUGS. Zenaida N. Maglaya,MD,FPSECP Department of Pharmacology. SEIZURE. Is a finite episodes of brain dysfunction resulting from abnormal discharge of cerebral neurons. PRIMARY SEIZURES SECONDARY SEIZURES. CLASSIFICATION OF SEIZURE TYPES. PARTIAL SEIZURES
E N D
ANTISEIZURE DRUGS Zenaida N. Maglaya,MD,FPSECP Department of Pharmacology
SEIZURE • Is a finite episodes of brain dysfunction resulting from abnormal discharge of cerebral neurons. • PRIMARY SEIZURES • SECONDARY SEIZURES
CLASSIFICATION OF SEIZURE TYPES PARTIAL SEIZURES • Simple partial seizures • Complex partial seizures • Partial seizures secondarily generalized
CLASSIFICATION OF SEIZURE TYPES GENERALIZED SEIZURES • Generalized tonic-clonic (grand mal) Sz • Absence (petit mal) seizures • Tonic/ Atonic Seizures • Clonic & myoclonic seizures • Infantile Spasms • Febrile Seizures • Status Epilepticus
PRIMARY DRUGS • CARBAMAZEPINE • PHENYTOIN • VALPROIC ACID • PHENOBARBITAL • PRIMIDONE • DIAZEPAM /LORAZEPAM • CLONAZEPAM • ETHOSUXIMIDE
ADJUNCTIVE DRUGS FELBAMATE GABAPENTIN LAMOTRIGINE TIAGABINE TOPIRAMATE VIGABATRIN LEVETIRACETAM ZONISAMIDE
ANTISEIZURES CLASSIFICATION I. TONIC-CLONIC & PARTIAL SEIZURES • Carbamazepine. Phenytoin, valproic acid II.ABSENCE SEIZURES • Ethosuximide, valproic acid, clonazepam III MYOCLONIC SEIZURES • Valproic acid, clonazepam IV. ADJUNCT/NEWER ANTICONVULSANTS
MECHANISM OF ACTION • Inhibition of sodium channels function: phenytoin, carbamazepine, lamotrigine • Inhibition of calcium channel function:ethosuximde • Enhancement of GABA action: benzodiazepines,phenobarbital gabapentin,vigabatrin, tiagabine • Multiple & Complex Mechanism: Valproic Acid
PHENYTOIN • BLOCK SODIUM CHANNELS • USE: partial seizures; generalized tonic-clonic seizures, Antiarrhymic drug0 • Oral, IV • highly bound to plasma proteins • T ½ 12 -36 hrs • Metabolized, dose dependent elimination • Fosphophytoin, mephenytoin, ethotoin. • phenacemide
Phenytoin Adverse Effects • nystagmus, diplopia, ataxia, sedation, gingival hyperplasia & hirsutism, coarsening of facial features, mild peripheral neuropathy, megaloblastic anemia fever, skin rash, fetal hydantoin syndrome
PHENYTOIN DRUG INTERACTIONS • Sulfonamides, valproate & phenylbutazone: displace phenytoin from binding sites • Cimetidine, disulfiram, doxycycline, isoniazid, phenylbutazone, sulfas, warfarin, chloramphenicol: inhibits phenytoin metabolism
PHENYTOIN DRUG INTERACTIONS 3.Barbiturates & carbamazepine, pyridoxine, theophylline: enhance phenytoin metabolism 4.PHENYTOIN decreasesserum levels of: carbamazepine, chloramphenicol, corticosteroids, haloperidol, quinidine, theophylline, oral contraceptives, warfarin
CARBAMAZEPINE • BLOCK SODIUM CHANNELS • DOC for partial seizures • Generalized tonic-clonic seizures • Trigeminal neuralgia • Mania:bipolar disorders • Orally absorbed with slow distribution • Completely metabolized • CAUSE: diplopia & ataxia, idiosyncratic blood dyscrasias, aplastic anemia & agranulocytosis, leukopenia
CARBAMAZEPINE DRUG INTERACTIONS 1. Increase carbamazepine levels via metabolism: cimetidine, erythromycin, isoniazid 2. Decrease carbamazepine levels via increase metabolism: phenytoin, valproic acid 3. Carbamazepine decreases drug levels :warfarin, oral contraceptives, doxycycline, phenytoin, haloperidol 4. Carbamazepine increases drug levels : cimetidine, isoniazid 5. Lithium induces carbamazepine toxicity.
PHENOBARBITAL • Enhancement of inhibitory process • Dimimution of excitatory transmission • USE: partial seizures, generalized tonic-clonic seizures • May cause: CNS depression • Tolerance & dependence CI in porphyria disorders
PHENOBARBITAL DRUG INTERACTIONS • Increase phenobarbital levels via metabolism; acute ethanol ingestion, chloramphenicol, valproic acid • Decrease phenobarbital levels via increase metabolism, chronic alcohol ingestion, pyridoxine, rifampin • Barbiturates decrease serum levels: tricyclics, warfarin, beta blockers, oral contraceptives, digitoxin, doxycycline, metronidazole, theophyllline
PRIMIDONE • Metabolized to: • PHENOBARBITAL • PHENYLETHYLMALONAMIDE(PEMA) • Mechanism of action similar to phenytoin • May cause sedation, ataxia, vertigo, GIT upset, megaloblastic anemia • CI: porphyria, hypersensitivity
VIGABATRIN • Inhibits GABA transaminase • Partial seizures & ‘WEST syndrome • In patients unresponsive to conventional drugs • Rapid absorption • T ½ 6 -8 hrs • CAUSES: drowsiness, behavioral & mood changes, weight gain, visual field defect
LAMOTRIGINE • Inhibits sodium channels • Partial seizures • Absense seizures • Completely absorbed • T ½ of 24 hours • Broad therapeutic profile • CAUSES: hypersensitivity rxns, diplopia, ataxia, headache, dizziness, life threatening skin disorders, hematotoxicity
FELBAMATE • MOA is unknown • For partial seizures • Broad therapeutic profile • For intractable cases • T ½ is 20 hrs • CAUSES: severe hypersensitivity rxs aplastic anemia, hepatotoxicity • Increase plasma phenytoin & valproic acid • Decrease carbamazepine levels
GABAPENTIN • MOA: alters GABA metabolism, its nonsynaptic release or its reuptake by GABA transporters • Also binds to the α2δ subunit of voltage sensitive calcium channels • FOR PARTIAL & GENERALIZED SEIZURES • SATURABLE ABSORPTION CAUSE: somnolence, dizziness, ataxia, headache & tremor
TOPIRAMATE • Complex action: GABA effect, blocks voltage dependent sodium channels • Similar to phenytoin with lower side effects & simpler pharmacokinetics • Risk of teratogenesis • Sedation, mental dulling, renal stones, weight loss
TIAGABINE • Nicotinic acid derivative • GABA uptake inhibitor in both neurons & glia • Partial seizures • Dizziness, tremor, difficulty in concentration, psychosis
ETHOSUXIMIDE • DOC for absense seizures • Effect on calcium channels( reduce low threshold (T type) currents • Inhibits NA/K/ ATPase, depresses the cerebral metabolic rate & inhibits GABA aminotransferase • Absorption is complete • Completely metabolized • CAUSES; gastric distress, lethargy & headache • DI: valproic acid inhibits its metabolixm
VALPROIC ACID • On partial seizures sodium channel effects • Increased levels of GABA inhibits GABA transaminase & succinic semialdehyde dehydrogenase • Sodium channel blockade
VALPROIC ACID • CLINICAL USES: 1. ABSENCE SEIZURES 2. MYOCLONIC SEIZURES 3. GENERALIZED TONIC-CLONIC TYPE OF SEIZURES 4. ATONIC ATTACKS 5. PARTIAL SEIZURES 6. MIGRAINE PROPHYLAXIS 7. BIPOLAR DISORDER
VALPROIC ACID • Well absorbed; ppc within 2 hrs • Bioavailability > 80% • T ½ is 9 -18 hrs • CAUSES: nausea, vomiting, pain & heart burn, sedation uncommon, fine tremors, weight gain, increase in appetite & hair loss, hepatotoxicity, thrombocytopenia, • SPINA BIFIDA
VALPROIC DRUG INTERACTIONS • Decrease valproic acid levels from increase metabolism with carbamazepine • Increase valproic acid levels with antacid (increase absorption) • salicylates (displacements from binding sites) • When used with clonazepam may precipitate absence status
BENZODIAZEPINES • Diazepam, lorazepam, clonazepam, clorazepate, Nitrazepam, clobazam • Well absorbed, widely distributed • Extensively metabolized with many active metabolites • May cause sedation, tolerance • DIAZEPAM: DOC for status epilepticus
STATUS EPILPETICUS • DIAZEPAM • LORAZEPAM • PHENYTOIN • PHENOBARBITAL
Thank You!!! And we know that all things work together for good to those who love God, to those who who are called according to His purpose. ROMANS 8: 28